期刊文献+

几种小分子c-Met抑制剂类抗肿瘤药物概述 被引量:1

下载PDF
导出
摘要 癌症现已成为社会家庭的严重负担,特别是对患者本身带来的精神以及生理上的痛苦是巨大的。由于小分子c-Met抑制剂类抗肿瘤药物具有耐受性好、对抗肿瘤的发生和转移的特点,使其迅速成为目前抗肿瘤药物研究的热点。这类药物中的c-Met抑制剂作用于c-Met受体,达到抑制c-Met结合域磷酸化,阻止酪氨酸激酶活化从而抑制下游信号传导产生抗肿瘤作用。本文主要就各种小分子c-Met抑制剂类抗肿瘤药物的研究概况进行阐述。
出处 《江西中医药》 2018年第10期77-80,共4页 Jiangxi Journal of Traditional Chinese Medicine
  • 相关文献

参考文献5

二级参考文献29

  • 1BLUME-JENSEN P,HUNTER T.Oncogenic kinase signaling[J].Nature,2001,411(6835):355-365.
  • 2MANNING G,WHYTE D B,MARTINEZ R,et al.The protein kinase complement of the human genome[J].Science,2002,298(5600):1912-1934.
  • 3LEMMON M A,SCHLESSINGER J.Cell signaling by receptor tyrosine kinases[J].Cell,2010,141(7):1117-1134.
  • 4BOLEN J B.Nonreceptor tyrosine protein kinases[J].Oncogene,1993,8(8):2025-2031.
  • 5GHERARDI E,YOULES M E,MIGUEL R N,et al.Functional map and domain structure of MET,the product of the MET proto-oncogene and receptor for hepatocyte growth factor/scatter factor[J].Proc Nati Acad Sci USA,2003,100(21):12039-12044.
  • 6BASILICO C,ARNESANO A,GALLUZZO M,et al.A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of MET[J].J Biol Chem,2008,283(30):21267-21277.
  • 7EDER J P,VANDE WOUDE G F,BOERNER S A,et al.Novel therapeutic inhibitors of the c-Met signaling pathway in cancer[J].Clin Cancer Res,2009,15(7):2207-2214.
  • 8MOSESSON Y,MILLS G B,YARDEN Y.Derailed endocytosis:An emerging feature of cancer[J].Nat Rev Cancer,2008,8(11):835-850.
  • 9CUI J J,TRAN-DUBEM,SHEN H,et al.Structure based drug design of crizotinib(PF-02341066),a potent and selective dual inhibitor ofmesenchymal-epithelial transition factor(MET)kinase and anaplastic lymphoma kinase(ALK)[J].J Med Chem,2011,54(18):6342-6363.
  • 10LIU X,WANG Q,YANG G,et al.A novel kinase inhibitor,INCB28060,blocks MET-dependent signaling,neoplastic activities,and cross-talk with EGFR and HER-3[J].Clin Cancer Res,2011,17(22):7127-7138.

共引文献34

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部